|
88
|
276
|
4txcA |
Crystal structure of dapk1 kinase domain in complex with a small molecule inhibitor |
|
107
|
333
|
4ubaA |
Low-salt structure of protein kinase ck2 catalytic subunit with 4'-carboxy-6,8-bromo-flavonol (flc26) |
|
55
|
290
|
4tthB |
Crystal structure of a cdk6/vcyclin complex with inhibitor bound |
|
67
|
273
|
4rzvA |
Crystal structure of the braf (r509h) kinase domain monomer bound to vemurafenib |
|
79
|
275
|
4u5jA |
C-src in complex with ruxolitinib |
|
71
|
273
|
4rzwA |
Crystal structure of braf (r509h) kinase domain bound to az628 |
|
84
|
308
|
4tygA |
Structural analysis of the human fibroblast growth factor receptor 4 kinase |
|
94
|
348
|
4tyhB |
Ternary complex of p38 and mk2 with a p38 inhibitor |
|
99
|
350
|
4tyhA |
Ternary complex of p38 and mk2 with a p38 inhibitor |
|
96
|
297
|
4twnA |
Human epha3 kinase domain in complex with birb796 |
|
94
|
290
|
4u8zA |
Crystal structure of mst3 with a pyrrolopyrimidine inhibitor (pf-06447475) |
|
87
|
301
|
4rwlA |
Crystal structure of fgfr1 (c488a, c584c) in complex with 6-(7-((1-aminocyclopropyl) methoxy)-6-methoxyquinolin-4-yloxy)-n-methyl-1-naphthamide (e3810) |
|
106
|
357
|
4u79A |
Crystal structure of human jnk3 in complex with a benzenesulfonamide inhibitor. |
|
81
|
298
|
4u43A |
Map4k4 in complex with inhibitor (compound 6) |
|
90
|
305
|
4rwiA |
Crystal structure of v561m fgfr1 gatekeeper mutation (c488a, c584s, v561m), apo |
|
87
|
271
|
4rssA |
Crystal structure of tyrosine-protein kinase syk with an inhibitor |
|
86
|
293
|
4u9aA |
Sulphur anomalous crystal structure of asymmetric irak4 dimer |
|
82
|
295
|
4u41A |
Map4k4 bound to inhibitor compound 1 |
|
99
|
295
|
4u3yA |
Apo mitogen-activated protein kinase kinase kinase kinase 4 (map4k4) |
|
90
|
275
|
4rx7A |
Syk catalytic domain complexed with a potent triazine inhibitor |
|
75
|
266
|
4ueuA |
Tyrosine kinase as - a common ancestor of src and abl |
|
88
|
295
|
4u40A |
Mitogen-activated protein kinase kinase kinase kinase 4 (map4k4) bound to amppnp |
|
111
|
351
|
4s32A |
Crystal structure of erk2 amp-pnp complex |
|
173
|
529
|
4tndA |
Crystal structure of g protein-coupled receptor kinase 5 in complex with amp-pnp |
|
90
|
352
|
4rt7A |
Crystal structure of flt3 with a small molecule inhibitor |
|
91
|
298
|
4twoA |
Human epha3 kinase domain in complex with compound 164 |
|
78
|
277
|
4trlA |
Structure of ephrin type-a receptor 2 |
|
123
|
403
|
4u6rA |
Crystal structure of human ire1 cytoplasmic domains in complex with a sulfonamide inhibitor. |
|
93
|
300
|
4u45A |
Map4k4 in complex with inhibitor (compound 25) |
|
175
|
529
|
4tnbA |
Crystal structure of g protein-coupled receptor kinase 5 in complex with sangivamycin |
|
127
|
419
|
4ualA |
Mrck beta in complex with bdp00005290 |
|
85
|
271
|
4rvkA |
Chk1 kinase domain with diazacarbazole compound 8: n-[3-(6-cyano-9h-pyrrolo[2,3-b:5,4-c']dipyridin-3-yl)phenyl]acetamide |
|
88
|
299
|
4u44A |
Map4k4 in complex with inhibitor (compound 16) |
|
158
|
466
|
4tzrA |
Calcium-dependent protein kinase 1 from toxoplasma gondii (tgcdpk1) in complex with inhibitor uw1561 |
|
82
|
308
|
4rwkA |
Crystal structure of v561m fgfr1 gatekeeper mutation (c488a, c584s, v561m) in complex with n-{3-[2-(3,5-dimethoxyphenyl)ethyl]-1h-pyrazol-5-yl}-4-[(3r,5s)-3,5-dimethylpiperazin-1-yl]benzamide (azd4547) |
|
82
|
296
|
4rvtA |
Map4k4 in complex with a pyridin-2(1h)-one derivative |
|
80
|
302
|
4tptA |
Crystal structure of the human limk2 kinase domain in complex with a non-atp competitive inhibitor |
|
112
|
352
|
4s33A |
Erk2 r65s mutant complexed with amp-pnp |
|
100
|
311
|
4u0iA |
Crystal structure of kit in complex with ponatinib |
|
145
|
478
|
4qoxA |
Crystal structure of cdpk4 from plasmodium falciparum, pf3d7_0717500 |
|
100
|
326
|
4r7hA |
Crystal structure of fms kinase domain with a small molecular inhibitor, plx3397 |
|
88
|
308
|
4qqcA |
Crystal structure of fgf receptor (fgfr) 4 kinase domain in complex with fiin-2, an irreversible tyrosine kinase inhibitor capable of overcoming fgfr kinase gate-keeper mutations |
|
95
|
302
|
4r7iA |
Crystal structure of fms kinase domain with a small molecular inhibitor, gleevec |
|
157
|
490
|
4rgjA |
Apo crystal structure of cdpk4 from plasmodium falciparum, pf3d7_0717500 |
|
108
|
345
|
4qp4A |
Crystal structure of erk2 in complex with n-cyclohexyl-9h-purin-6-amine |
|
108
|
341
|
4qyyA |
Discovery of novel, dual mechanism erk inhibitors by affinity selection screening of an inactive kinase state |
|
97
|
285
|
4qmtA |
Mst3 in complex with hesperadin |
|
90
|
345
|
4qpmA |
Structure of bub1 kinase domain |
|
91
|
322
|
4rj4A |
Egfr kinase (t790m/l858r) with inhibitor compound 6 |
|
89
|
263
|
4rg0A |
Crystal structure of btk kinase domain complexed with 2-[8-fluoro-2-[2-(hydroxymethyl)-3-[1-methyl-5-[[5-(4-methylpiperazin-1-yl)-2-pyridyl]amino]-6-oxo-3-pyridyl]phenyl]-1-oxo-3,4-dihydroisoquinolin-6-yl]-2-methyl-propanenitrile |
